Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1060/week)
Manufacturing
(521/week)
Energy
(395/week)
Technology
(994/week)
Other Manufacturing
(316/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Tris Pharma, Inc.
Feb 22, 2021
Tris Pharma and Athena Bioscience Announce Exclusive License Agreement to Commercialize Near-to-Market Long-Acting Antihypertensive Product in the U.S.
Jan 28, 2021
APSARD and Tris Pharma Announce the 2021 Tris Research Award in ADHD
Jan 20, 2021
Tris Pharma Presents Positive Results from Phase 3 Study of Amphetamine Extended-Release Tablet in Adults with ADHD
Jan 15, 2021
Tris Pharma to Debut Amphetamine Extended-Release Tablet Efficacy and Safety Data at the 2021 APSARD Annual Meeting
Dec 18, 2020
Tris Pharma Hires Seasoned Research & Development Executive
Dec 08, 2020
Tris Pharma and Neuraxpharm Group Announce Partnership to Commercialize Tris' Quillivant XR and Quillichew ER in Europe
Dec 01, 2020
Tris Announces US District Court Upholds Validity of Quillivant XR® Patents; Rules Teva Infringes Tris Patents
Nov 17, 2020
Tris Pharma and Medison Pharma Announce Exclusive License Agreement to Commercialize Tris' Quillivant XR in Israel
Nov 10, 2020
Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers
Oct 22, 2020
Tris Pharma to Present Amphetamine Extended-Release Tablet Data at the Research Pipeline Session of 2020 American Academy of Child and Adolescent Psychiatry Meeting
Oct 06, 2020
Tris Pharma Launches its Scientific Advisory Board
Sep 17, 2020
Tris Pharma Launches Redesigned Website for ADHD Healthcare Professionals
Jul 09, 2020
Tris Pharma and KYE Pharmaceuticals Announce Exclusive License Agreement to Commercialize Tris ADHD Products in Canada
Jun 25, 2020
Tris Pharma Launches New Corporate Website
Mar 17, 2020
Quillivant XR®, QuilliChew ER® and Dyanavel® XR are 100% Made in the U.S.A. and Remain Consistently Supplied During COVID-19 Pandemic
Jan 17, 2020
APSARD and Tris Pharma Announce the Inaugural Tris Research Award in ADHD
Nov 07, 2019
Tris Pharma to Present Two Posters for Amphetamine Extended-Release Tablet at the 2019 Neuroscience Education Institute (NEI) Congress
Oct 30, 2019
Tris Pharma Adds Seasoned Attorney to its Senior Leadership Team
Sep 04, 2019
Tris Pharma Strengthens Its Branded Commercial Leadership Team
Aug 14, 2019
Tris Pharma Chief Medical Officer Elected to the American Psychiatric Association Assembly Executive Committee
Page 1
››
Latest News
Jul 13, 2025
Australia says China likely to spy on military drills with US
Jul 12, 2025
Lioran Vesse Launches Orbis IA 6.0 at École de commerce Valmont to Revolutionize Intelligent Finance
Jul 12, 2025
VERTEX Strengthens Leadership Team with Key Executive Appointments and New Board Members
Jul 12, 2025
Gravity Launches How to Train Your Dragon Collaboration for Ragnarok Online
Jul 12, 2025
Pomerantz Law Firm Announces the Filing of a Class Action Against Apple Inc. and Certain Officers - AAPL...
Jul 12, 2025
CGTN: Bridging dialogue: China promotes integration, mutual learning among civilizations
Jul 12, 2025
Boeing evades MAX crash trial with last-minute settlement
Jul 12, 2025
Sensient Announces Conference Call
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events